Clinical Trials Browser

Exanthema

NCT07426822 2026-02-24

SAFE-CAP

Phase 2 Not yet recruiting

108 enrolled

Diarrhea, Exanthema

NCT03363763 2025-12-01

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

Phase 2 Terminated

24 enrolled 11 charts

Erythema, Exanthema, Fibroma, Tuberous Sclerosis, Facies

NCT06399029 2025-11-19

TRUX-LST

Phase 2 Recruiting

20 enrolled

Exanthema

NCT01880515 2025-05-11

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Phase 2 Completed

107 enrolled 8 charts

Thoracic

Exanthema, Lung Neoplasms

NCT03992664 2025-02-13

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

Phase NA Completed

40 enrolled

BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Exanthema, Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Photosensitivity Disorders, Pruritus

NCT05966584 2024-08-29

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

Phase 2 Terminated

1 enrolled 5 charts

Breast

Breast Neoplasms, Exanthema

NCT04878692 2021-05-07

OPERA

Phase NA Unknown

96 enrolled

GastrointestinalHead & NeckThoracic

Acne Vulgaris, Carcinoma, Non-Small-Cell Lung, Exanthema, Head and Neck Neoplasms, Colorectal Neoplasms

NCT03440515 2020-01-07

Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor

Phase 2 Completed

29 enrolled

GastrointestinalSarcoma

Exanthema, Gastrointestinal Stromal Tumors

NCT02239731 2018-02-27

Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients

Phase 2 Completed

24 enrolled

Exanthema

NCT01136005 2017-11-13

BeCet

Phase 3 Completed

160 enrolled

Exanthema, Neoplasms

NCT00473083 2017-04-04

LUTRAERL

Phase 2 Completed

150 enrolled 13 charts

Thoracic

Exanthema, Lung Neoplasms

NCT01931150 2017-01-13

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Phase 3 Completed

11 enrolled 7 charts

Gastrointestinal

Exanthema, Colorectal Neoplasms

NCT00332163 2016-02-23

STEPP

Phase 2 Completed

95 enrolled 23 charts

Gastrointestinal

Colonic Neoplasms, Exanthema, Rectal Neoplasms, Colorectal Neoplasms

NCT00803842 2015-02-26

Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash

Phase NA Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Exanthema

NCT01315990 2013-12-18

DERMATUX

Phase 4 Unknown

165 enrolled

Gastrointestinal

Exanthema, Colorectal Neoplasms

NCT01299220 2013-01-16

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

Phase 4 Withdrawn

Exanthema, Neoplasms

NCT00343187 2011-05-30

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Phase 2 Terminated

2 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Exanthema

NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Phase 4 Completed

452 enrolled

Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis

Clinical Trials

TREATS

SAFE-CAP

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

TRUX-LST

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

OPERA

Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor

Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients

BeCet

LUTRAERL

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

STEPP

Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash

DERMATUX

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Subcutaneous Amifostine Safety Study